GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axonics Inc (MEX:AXNX) » Definitions » Sale Of Investment

Axonics (MEX:AXNX) Sale Of Investment : MXN7,265 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Axonics Sale Of Investment?

Axonics's sale of investment for the three months ended in Mar. 2024 was MXN2,805 Mil. It means Axonics gained MXN2,805 Mil from selling investments. Axonics's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was MXN7,265 Mil.

Compared with last quarter (MXN1,716 Mil in Dec. 2023 ), Axonics gained more money from selling investments in Mar. 2024 (MXN2,805 Mil).


Axonics Sale Of Investment Historical Data

The historical data trend for Axonics's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axonics Sale Of Investment Chart

Axonics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial 1,565.95 250.48 - 1,110.86 5,317.18

Axonics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 969.69 924.74 1,819.20 1,715.67 2,805.32

Axonics Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN7,265 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Axonics Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Axonics's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Axonics (MEX:AXNX) Business Description

Traded in Other Exchanges
Address
26 Technology Drive, Irvine, CA, USA, 92618
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.